4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-12-001408
Options or other derivatives
- Director acquired 67,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GERMAIN MARK · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-08-28 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +67,500 | $0.64 | 2022-08-28 | 67,500 | 1,076,700 | D |
Loading xslF345X03/form4-09252012_020933.xml…